Bolstering Cash on Hand in Response to the COVID-19 Pandemic
First written in FY2021-Q1. 6 of 16 entries say "Softened", first in FY2023-Q1. Latest entry: FY2026-H1.
0 other companies' latest entry also says "Other".
- FY2026-H1Cash and Cash Equivalents IncreasedAnnual report
「Change in cash and cash equivalents (△ indicates a decrease) 1,491」
Cash and cash equivalents increased by ¥1,491 million in the interim period, compared with a modest increase in the same period of the previous year, bringing the balance at period-end to ¥16,905 million. There was no disclosure attributing the buildup of cash reserves directly to the response to the infectious disease. - FY2025-H1Cash and cash equivalents increased slightlyAnnual report
「Change in cash and cash equivalents (△ indicates a decrease) 162」
Cash and cash equivalents increased by ¥162 million during the interim period. There was no disclosure directly attributing this to the buildup of cash reserves in response to the spread of the infectious disease, and the increase was modest after the previous upward trend weakened. - FY2025-Q1SoftenedAnnual report
「This was mainly due to a ¥2,765 million decrease in cash and deposits.」
Cash and deposits decreased by ¥2,765 million from the end of the previous fiscal year, further weakening the buildup in cash reserves that had continued in response to the infectious disease outbreak. - FY2024SoftenedAnnual report
「Cash and cash equivalents at the end of the period decreased by ¥3,524 million from the end of the previous fiscal year to ¥11,158 million.」
Cash reserves decreased from ¥14,683 million at the end of the previous fiscal year to ¥11,158 million, weakening the buildup trend in response to the infectious disease outbreak. - FY2024-Q3SoftenedAnnual report
「Cash and deposits 15,376 12,494」
Cash and deposits decreased from ¥15,376 million at the end of the previous fiscal year to ¥12,494 million, weakening the trend of building up cash reserves. - FY2024-Q1SoftenedAnnual report
「This was mainly due to a ¥3,092 million decrease in cash and deposits.」
Cash and deposits decreased by ¥3,092 million from the end of the previous fiscal year, weakening the buildup in cash reserves that had continued through the previous quarter. - FY2023-Q3Cash and deposits increased from the end of the previous fiscal yearAnnual report
「Cash and deposits 14,350 15,815」
Cash and deposits at the end of the third quarter stood at ¥15,815 million, up from ¥14,350 million at the end of the previous fiscal year. - FY2023-Q2SoftenedAnnual report
「Cash and cash equivalents at the end of the quarter (fiscal year) stood at ¥12,614 million.」
Cash and cash equivalents decreased from ¥13,864 million at the end of the previous fiscal year to ¥12,614 million, weakening the trend of building up cash reserves in response to the infectious disease outbreak. - FY2023-Q1SoftenedAnnual report
「Cash and deposits decreased from ¥14,350 million to ¥14,064 million.」
Cash and deposits decreased by ¥286 million from the end of the previous fiscal year, weakening the previously continuing upward trend in cash reserves. - FY2022-Q3Cash and deposits continued to increase, but the amount of the increase declinedAnnual report
「This was primarily because, although notes and accounts receivable decreased by ¥2,751 million, cash and deposits increased by ¥2,451 million, raw materials and supplies increased by ¥2,377 million, and tangible fixed assets increased by ¥2,049 million in connection with construction of a new research and development building.」
Cash reserves continued to increase, but the increase declined from ¥3,399 million from the end of the previous fiscal year, as reported for the preceding quarter, to ¥2,451 million. - FY2022-Q2Continued Increase in Cash and DepositsAnnual report
「This was mainly due to a ¥3,399 million increase in cash and deposits and a ¥925 million increase in property, plant and equipment associated with construction of the new research and development building.」
Cash and deposits increased by ¥3,399 million from the end of the previous fiscal year, and the increase in cash reserves continued. - FY2022-Q1Continued Increase in Cash and DepositsAnnual report
「This was mainly due to a ¥4,096 million increase in cash and deposits and a ¥1,026 million increase in property, plant and equipment associated with construction of the new research and development building.」
Cash and deposits increased by ¥4,096 million from the end of the previous fiscal year, and the company continued building up cash reserves. - FY2021AdvancedAnnual report
「Cash and cash equivalents at the end of the current fiscal year increased by ¥3,128 million from the end of the previous fiscal year to ¥14,804 million.」
The company continued securing funding liquidity, including as a precaution against the infectious disease, and cash and cash equivalents increased by ¥3,128 million from the end of the previous fiscal year. - FY2021-Q3AdvancedAnnual report
「Total assets at the end of the third quarter of the current fiscal year were ¥87,878 million, up 15.4% from the end of the previous fiscal year. This was primarily because cash and deposits increased as the company built up cash reserves in view of the spread of COVID-19.」
The company continued building up cash reserves as a precaution against the infectious disease, and the increase in total assets from the end of the previous fiscal year expanded from 9.5% in the second quarter to 15.4%. Cash and deposits amounted to ¥21,751 million. - FY2021-Q2AdvancedAnnual report
「Total assets at the end of the second quarter of the current fiscal year were ¥83,386 million, up 9.5% from the end of the previous fiscal year. This was primarily because cash and deposits increased as the company built up cash reserves in view of the spread of COVID-19.」
The company continued building up cash reserves as a precaution against COVID-19, and cash and deposits increased from ¥12,143 million at the end of the previous fiscal year to ¥18,428 million. - FY2021-Q1First statedAnnual report
「This was primarily because cash and deposits increased as the company built up cash reserves in view of the spread of COVID-19, while inventories of products increased as demand declined.」
The company implemented cash management measures to build up cash reserves in preparation for the spread of the infectious disease and unforeseen events. An increase in short-term borrowings was also disclosed.